In addition, heme degradation by HMOX1 in tumor cells seems to support cancer by counteracting oxidative stress during tumorigenesis and upon anti-tumor therapies, but concomitantly to promote TAMs acquisition of a M1-like phenotype, favoring tumor regression and increased drug sensitivity. The gene discussed is HMOX1; the disease is cancer.